4.8 Article

Cholinergic Mesopontine Signals Govern Locomotion and Reward through Dissociable Midbrain Pathways

Journal

NEURON
Volume 90, Issue 2, Pages 333-347

Publisher

CELL PRESS
DOI: 10.1016/j.neuron.2016.03.028

Keywords

-

Categories

Funding

  1. NIH [IDP20D017782-1, BRAIN 1U01NS090577]
  2. PECASE
  3. NIH/NIA [1R01AG047664-01]
  4. Heritage Medical Research Institute
  5. Pew Charitable Trust
  6. Michael J. Fox Foundation
  7. Sloan Foundation
  8. Beckman Institute for the Resource Center on CLARITY, Optogenetics, and Vector Engineering for technology development and broad dissemination
  9. NIH/NIMH [1R21MH103824-01]
  10. Kimmel Foundation
  11. Human Frontiers in Science Program
  12. Mallinckrodt Foundation
  13. Gordon and Betty Moore Foundation [GBMF2809]
  14. Caltech-GIST
  15. Caltech-CBEA
  16. Caltech-CEMI
  17. Caltech-City of Hope Biomedical Initiative
  18. NIH Predoctoral Training in Biology and Chemistry [2T32GM007616-36]

Ask authors/readers for more resources

The mesopontine tegmentum, including the pedunculopontine and laterodorsal tegmental nuclei (PPN and LDT), provides major cholinergic inputs to midbrain and regulates locomotion and reward. To delineate the underlying projection-specific circuit mechanisms, we employed optogenetics to control mesopontine cholinergic neurons at somata and at divergent projections within distinct midbrain areas. Bidirectional manipulation of PPN cholinergic cell bodies exerted opposing effects on locomotor behavior and reinforcement learning. These motor and reward effects were separable via limiting photostimulation to PPN cholinergic terminals in the ventral substantia nigra pars compacta (vSNc) or to the ventral tegmental area (VTA), respectively. LDT cholinergic neurons also form connections with vSNc and VTA neurons; however, although photoexcitation of LDT cholinergic terminals in the VTA caused positive reinforcement, LDT-to-vSNc modulation did not alter locomotion or reward. Therefore, the selective targeting of projection-specific mesopontine cholinergic pathways may offer increased benefit in treating movement and addiction disorders.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available